Clinical Trials Logo

Clinical Trial Summary

Decoria intense is a class III medical device and is CE-marked and has been on the market since 2014. Decoria intense is a hyaluronic acid filler that will be used according to intended use for correction of nasolabial folds. According to the new MDR in EU this clinical investigation will confirm efficacy and safety of Decoria intense. The plan is to recruit 80 subjects to receive 64 evaluable subjects during 6 months recruitment. The clinical investigation contains 5 visits and the total time per subject is 12 months. All subjects will receive treatment at Visit 1 with the option to receive a touch-up treatment at Visit 2. Evaluation of the nasolabial folds will be performed by PI using the Wrinkle Severity Rating Scale (WSRS)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05235126
Study type Interventional
Source Bohus Biotech AB
Contact
Status Completed
Phase N/A
Start date February 17, 2022
Completion date March 3, 2023

See also
  Status Clinical Trial Phase
Completed NCT02334358 - Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s
Completed NCT03611491 - Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds N/A
Completed NCT05106751 - A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds Phase 4
Completed NCT02661737 - Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s
Completed NCT02179606 - Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus Phase 3
Completed NCT03650218 - Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds N/A
Completed NCT02179619 - Clinical Study to Evaluate the Efficacy and Safety of Dermalax(Deep) in Correction of Nasolabial Folds Phase 3
Unknown status NCT01492140 - Injection Assistance Device Versus Manual Injections for Delivery of Dermal Fillers Phase 4